Elasmogen
PrivateLast Round
Series A
May 18, 2022
Total Funding Raised
$17.82M
Company Overview
Elasmogen is a biopharmaceutical company that develops therapeutic biologics, specifically soloMERs, for the treatment of cancer and inflammatory, autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elasmogen Comparables
Compare Elasmogen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ossianix | 83% | |
| Cortalix B.V. | 82% | |
| Singh Biotechnology | 78% |
Elasmogen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 18, 2022 | ||||
| Grant | Jul 8, 2020 | ||||
| Seed | Jan 10, 2020 | ||||
| Grant | Mar 16, 2017 | ||||
| Seed | Mar 16, 2017 | ||||
Seed | Feb 1, 2016 |
Key People
Founding team and executive leadership
Elasmogen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BGF | Series A |
| Innovate UK | Grant |
| Deepbridge Capital | Seed, Grant |
| Scottish National Investment Bank | Series A |
| Biotechnology and Biological Sciences Research Council | Grant |
| Scottish Investment Bank (Scottish Enterprise) | Series A, Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 72% MoM, from 576 to 993.
- Apr 24, 2026
Monthly visitors grew 36% MoM.
Elasmogen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Elasmogen's valuation, stock price, and market status.
Is Elasmogen a public or private company?
Elasmogen is a private company.
What is the current stock price of Elasmogen?
Elasmogen is a private company with no public stock price. No recent secondary market data is available.
How much is Elasmogen worth (valuation)?
Valuation information for Elasmogen is not publicly available.
Can I buy Elasmogen stock?
Elasmogen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Elasmogen's last funding round?
Elasmogen's most recent funding round was Series A on May 18, 2022.
Who are the main investors in Elasmogen?
Key investors in Elasmogen include BGF, Deepbridge Capital, Scottish National Investment Bank.
Will Elasmogen IPO soon?
No public IPO plans have been announced for Elasmogen.
How can I track Elasmogen secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Elasmogen's secondary market activity and sign up for updates.